NCT06101498

Brief Summary

The aim of this study is to evaluate the effect of perioperative fluid management on postoperative kidney damage in gynecological cancer surgeries. The main question\[s\] it aims to answer are: Does fluid management applied with different hemodynamic monitoring methods affect the risk of postoperative AKI? In our clinic, three different fluid management strategies are applied depending on the anesthetist experience. Acute kidney injury will be evaluated according to the postoperative AKIN classification of conventional fluid therapy and targeted fluid therapy with noninvasive or minimally invasive monitoring.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 17, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

October 26, 2023

Completed
Last Updated

November 27, 2023

Status Verified

November 1, 2023

Enrollment Period

7 months

First QC Date

October 17, 2023

Last Update Submit

November 23, 2023

Conditions

Keywords

akut kidney injurygoal directed fluid therapyperoperative fluid managementconventional fluid therapy

Outcome Measures

Primary Outcomes (1)

  • Evaluation of acute kidney injury

    Our primary aim was to evaluate the postoperative day(POD1 ) creatinine values(mg/dl)

    Change from preoperative to postoperative day 1(POD1)creatinine values(mg/dl)

Secondary Outcomes (1)

  • Peroperative fluid amounts

    during the operation period

Other Outcomes (2)

  • The intensive care unit admission

    posoperatively up to 1 months

  • Length of stay

    postoperative 30 days

Study Arms (3)

Conventional fluid therapy

EXPERIMENTAL

Patients who received conventional fluid therapy

Diagnostic Test: Akut kidnet injury(AKI)

Non invaziv goal directed therapy

EXPERIMENTAL

Patients who received non invaziv goal directed therapy

Diagnostic Test: Akut kidnet injury(AKI)

Minimal invaziv goal directed therapy

EXPERIMENTAL

Patients who received minimal invaziv goal directed therapy

Diagnostic Test: Akut kidnet injury(AKI)

Interventions

postoperative 24 hours

Also known as: AKI developing in the patient group receiving conventional treatment, AKI developing in the patient group receiving non invaziv goal directed therapy, AKI developing in the patient group receiving minimal invaziv goal directed therapy
Conventional fluid therapyMinimal invaziv goal directed therapyNon invaziv goal directed therapy

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \>18 years
  • ASA II-III
  • Those with normal renal function

You may not qualify if:

  • Patients in renal insufficiency
  • Patients with perioperative renal, ureter \& bladder invasion
  • Patients in whom perioperative urine monitoring cannot be performed
  • Patients undergoing HIPEC
  • Patients with missing data

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Başakşehir Çam and Sakura City Hospital

Istanbul, Basaksehir, 3268, Turkey (Türkiye)

Location

Related Publications (5)

  • Yildiz GO, Hergunsel GO, Sertcakacilar G, Akyol D, Karakas S, Cukurova Z. Perioperative goal-directed fluid management using noninvasive hemodynamic monitoring in gynecologic oncology. Braz J Anesthesiol. 2022 May-Jun;72(3):322-330. doi: 10.1016/j.bjane.2021.12.012. Epub 2022 Feb 1.

  • Yu J, Che L, Zhu A, Xu L, Huang Y. Goal-Directed Intraoperative Fluid Therapy Benefits Patients Undergoing Major Gynecologic Oncology Surgery: A Controlled Before-and-After Study. Front Oncol. 2022 Apr 6;12:833273. doi: 10.3389/fonc.2022.833273. eCollection 2022.

  • Russo A, Aceto P, Grieco DL, Anzellotti GM, Perilli V, Costantini B, Romano B, Scambia G, Sollazzi L, Antonelli M. Goal-directed hemodynamic management in patients undergoing primary debulking gynaecological surgery: A matched-controlled precision medicine study. Gynecol Oncol. 2018 Nov;151(2):299-305. doi: 10.1016/j.ygyno.2018.08.034. Epub 2018 Sep 7.

  • Hasselgren E, Hertzberg D, Camderman T, Bjorne H, Salehi S. Perioperative fluid balance and major postoperative complications in surgery for advanced epithelial ovarian cancer. Gynecol Oncol. 2021 May;161(2):402-407. doi: 10.1016/j.ygyno.2021.02.034. Epub 2021 Mar 12.

  • McKenny M, Conroy P, Wong A, Farren M, Gleeson N, Walsh C, O'Malley C, Dowd N. A randomised prospective trial of intra-operative oesophageal Doppler-guided fluid administration in major gynaecological surgery. Anaesthesia. 2013 Dec;68(12):1224-31. doi: 10.1111/anae.12355. Epub 2013 Sep 30.

MeSH Terms

Conditions

EdemaPostoperative ComplicationsAcute Kidney Injury

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and SymptomsPathologic ProcessesRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Officials

  • Duygu Akyol

    Başakşehir Çam & Sakura City Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

October 17, 2023

First Posted

October 26, 2023

Study Start

January 1, 2023

Primary Completion

August 1, 2023

Study Completion

September 1, 2023

Last Updated

November 27, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations